Index by author

June 01, 2025; Volume 92,Issue 6

  1. Cavanaugh, Corey

    1. IgA nephropathy: Update on pathogenesis and treatment
      IgA nephropathy: Update on pathogenesis and treatment
      Seshma Ramsawak, MD, Scott Cohen, MD, Andrea Linares, DO and Corey Cavanaugh, DO
      Cleveland Clinic Journal of Medicine June 2025, 92 (6) 373-383; DOI: https://doi.org/10.3949/ccjm.92a.24105

      Renin-angiotensin-aldosterone system inhibitors or corticosteroids remain the cornerstone of therapy, but new agents targeting the different “hits” in the pathogenesis of IgA nephropathy are being introduced.

  2. Chirila, Razvan

    1. My adult patient’s hypercholesterolemia is not responding to statins—what’s next?
      Faaiq N. Aslam, MD, Mohamed G. Ibrahim, DO and Razvan Chirila, MD
      Cleveland Clinic Journal of Medicine June 2025, 92 (6) 347-351; DOI: https://doi.org/10.3949/ccjm.92a.24117

      Further investigation is needed when patients do not meet their target low-density lipoprotein cholesterol levels with statin therapy alone.

  3. Cohen, Scott

    1. IgA nephropathy: Update on pathogenesis and treatment
      IgA nephropathy: Update on pathogenesis and treatment
      Seshma Ramsawak, MD, Scott Cohen, MD, Andrea Linares, DO and Corey Cavanaugh, DO
      Cleveland Clinic Journal of Medicine June 2025, 92 (6) 373-383; DOI: https://doi.org/10.3949/ccjm.92a.24105

      Renin-angiotensin-aldosterone system inhibitors or corticosteroids remain the cornerstone of therapy, but new agents targeting the different “hits” in the pathogenesis of IgA nephropathy are being introduced.

Back to top

In this issue